There is actually 70 m savings in operating expenses , so Mayne is operating both Nexstellis and TXMD at profit for the first time , so they are correct 14 m +ve contribution and international segment always making profit , hopefully they add more dermatology products from similar companies to use the existing sales force . Smart idea
- Forums
- ASX - By Stock
- Mayne Pharma sees strong sales growth in FY 2023
There is actually 70 m savings in operating expenses , so Mayne...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.48 |
Change
0.070(1.29%) |
Mkt cap ! $466.2M |
Open | High | Low | Value | Volume |
$5.66 | $5.89 | $5.42 | $2.367M | 423.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1094 | $5.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.48 | 4817 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3514 | 5.370 |
1 | 1325 | 5.350 |
1 | 1200 | 5.320 |
1 | 370 | 5.260 |
1 | 238 | 5.250 |
Price($) | Vol. | No. |
---|---|---|
5.500 | 3500 | 1 |
5.550 | 1500 | 1 |
5.700 | 1200 | 1 |
5.770 | 2000 | 1 |
5.820 | 285 | 1 |
Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
Last
$5.47 |
  |
Change
0.070 ( 1.57 %) |
|||
Open | High | Low | Volume | ||
$5.71 | $5.85 | $5.43 | 72967 | ||
Last updated 15.59pm 24/05/2024 ? |
Featured News
MYX (ASX) Chart |